These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. New treatment guidelines for a patient with diabetes and hypertension. Mogensen CE J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164 [TBL] [Abstract][Full Text] [Related]
5. Microalbuminuria: a common, independent cardiovascular risk factor, especially but not exclusively in type 2 diabetes. Donnelly R; Yeung JM; Manning G J Hypertens Suppl; 2003 Mar; 21(1):S7-12. PubMed ID: 12769161 [TBL] [Abstract][Full Text] [Related]
6. [Hypertension, microalbuminuria and insulin resistance in diabetes mellitus]. Bretzel RG Wien Klin Wochenschr; 1994; 106(24):774-92. PubMed ID: 7846897 [TBL] [Abstract][Full Text] [Related]
7. Microalbuminuria and cardiovascular risk. Karalliedde J; Viberti G Am J Hypertens; 2004 Oct; 17(10):986-93. PubMed ID: 15485765 [TBL] [Abstract][Full Text] [Related]
9. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus. Agha A; Bashir K; Anwar E Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953 [TBL] [Abstract][Full Text] [Related]
10. Twelve shifting paradigms in diabetic renal disease and hypertension. Mogensen CE Diabetes Res Clin Pract; 2008 Nov; 82 Suppl 1():S2-9. PubMed ID: 18947897 [TBL] [Abstract][Full Text] [Related]
11. [Microalbuminuria in essential hypertension: of limited value as an indicator of patients with a high risk for complications]. Stehouwer CD; Jager A; Donker AJ Ned Tijdschr Geneeskd; 1997 Aug; 141(34):1649-53. PubMed ID: 9543776 [TBL] [Abstract][Full Text] [Related]
12. Slowing progression along the renal disease continuum. Kopyt NP J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338 [TBL] [Abstract][Full Text] [Related]
13. [Microalbuminuria is an early marker for increased morbidity and mortality]. Bramlage P; Wittchen HU; Pittrow D; Dikow R; Kirch W; Lehnert H; Ritz E Fortschr Med Orig; 2003 Feb; 121 Suppl 1():28-32. PubMed ID: 14732947 [TBL] [Abstract][Full Text] [Related]
14. Microalbuminuria as a risk factor: the influence of renin-angiotensin system blockade. Menne J; Chatzikyrkou C; Haller H J Hypertens; 2010 Oct; 28(10):1983-94. PubMed ID: 20634721 [TBL] [Abstract][Full Text] [Related]
15. [Diabetes and hypertension]. Sayk F; Iwen KA; Lehnert H Dtsch Med Wochenschr; 2009 Nov; 134(45):2296-301. PubMed ID: 19876807 [TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme inhibitors in diabetic patients with microalbuminuria or normoalbuminuria. Viberti G; Chaturvedi N Kidney Int Suppl; 1997 Dec; 63():S32-5. PubMed ID: 9407417 [TBL] [Abstract][Full Text] [Related]
17. Influence of microalbuminuria in achieving blood pressure goals. Duka I; Bakris G Curr Opin Nephrol Hypertens; 2008 Sep; 17(5):457-63. PubMed ID: 18695385 [TBL] [Abstract][Full Text] [Related]
18. The link between microalbuminuria, endothelial dysfunction and cardiovascular disease in diabetes. Naidoo DP Cardiovasc J S Afr; 2002; 13(4):194-9. PubMed ID: 12389063 [TBL] [Abstract][Full Text] [Related]
19. Microalbuminuria as a predictor of a drop in glomerular filtration rate in subjects with non-insulin-dependent diabetes mellitus and hypertension. Berrut G; Bouhanick B; Fabbri P; Guilloteau G; Bled F; Le Jeune JJ; Fressinaud P; Marre M Clin Nephrol; 1997 Aug; 48(2):92-7. PubMed ID: 9285145 [TBL] [Abstract][Full Text] [Related]
20. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better? Weir MR Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]